Inventor
KIRCHHOFER DANIEL K
US19 patents
⚠️ This page may combine multiple inventors who share the name “KIRCHHOFER DANIEL K”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GENENTECH INC
16 patentsUS6703494B2Mar 9, 2004
Anti-tissue factor antibodies with enhanced anticoagulant potency
GENENTECH INC28 citations92
US7825221B2Nov 2, 2010
Antibodies that bind hepatocyte growth factor activator
GENENTECH INC10 citations84
US6800604B2Oct 5, 2004
Polypeptides that inhibit human serum-induced cleavage of hepatocyte growth factor
GENENTECH INC15 citations84
US7622265B2Nov 24, 2009
Methods and compositions for modulating prostasin
GENENTECH INC10 citations83
US9266961B2Feb 23, 2016
Anti-PCSK9 antibodies, formulations, dosing, and methods of use
GENENTECH INC8 citations78
US7432044B2Oct 7, 2008
Methods and compositions for modulating hepatocyte growth factor activation
GENENTECH INC10 citations78
US11512143B2Nov 29, 2022
Anti-HtrA1 antibodies and methods of use thereof
GENENTECH INC1 citations71
US10421822B2Sep 24, 2019
Anti-HtrA1 antibodies and methods of use thereof
GENENTECH INC4 citations71
US10421821B2Sep 24, 2019
Anti-HtrA1 antibodies and methods of use thereof
GENENTECH INC2 citations71
US7741096B2Jun 22, 2010
Crystal structure of hepatocyte growth factor activator complexed with Kunitz domain inhibitor
GENENTECH INC7 citations65
US7737115B2Jun 15, 2010
HGF beta chain variants
GENENTECH INC3 citations62
US7435413B2Oct 14, 2008
Anti-tissue factor antibodies with enhanced anticoagulant potency
GENENTECH INC4 citations62
US8969528B2Mar 3, 2015
Antibodies to hepatocyte growth factor activator
GENENTECH INC0 citations52
US8383123B2Feb 26, 2013
Method of treatment targeting HEPSIN
GENENTECH INC0 citations50
US10246519B2Apr 2, 2019
NSP4 inhibitors and methods of use
GENENTECH INC0 citations47
US9975963B2May 22, 2018
NSP4 inhibitors and methods of use
GENENTECH INC1 citations47